Order Article Reprints

Alcaraz A, Rodríguez-Antolín A, Carballido-Rodríguez J, Castro-Díaz D, Esteban-Fuertes M, Cózar-Olmo JM, Ficarra V, Medina-López R, Fernández-Gómez JM, Angulo JC, et al. Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study. Journal of Clinical Medicine. 2020; 9(9):2909. https://doi.org/10.3390/jcm9092909

Alcaraz, Antonio, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, Manuel Esteban-Fuertes, José M. Cózar-Olmo, Vincenzo Ficarra, Rafael Medina-López, Jesús M. Fernández-Gómez, Javier C. Angulo, and et al. 2020. "Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study" Journal of Clinical Medicine 9, no. 9: 2909. https://doi.org/10.3390/jcm9092909

Alcaraz, A., Rodríguez-Antolín, A., Carballido-Rodríguez, J., Castro-Díaz, D., Esteban-Fuertes, M., Cózar-Olmo, J. M., Ficarra, V., Medina-López, R., Fernández-Gómez, J. M., Angulo, J. C., Medina-Polo, J., Brenes-Bermúdez, F. J., Molero-García, J. M., Fernández-Pro-Ledesma, A., Manasanch, J., & on behalf of The QUALIPROST Study Group. (2020). Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study. Journal of Clinical Medicine, 9(9), 2909. https://doi.org/10.3390/jcm9092909